Further, SARS-CoV-2 seems to trigger an innate functionality in a subset of T cells, namely highly activated CD16+ T cells, which occur mainly in severe COVID-19 in the CD4, CD8 and γδ T cell compartments [49]. This evidence concerns the gene CD8A and COVID-19.